Related Experiment Videos

[Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves]

Wei Zhuang1, Xin-Min Zhou, Jian-Guo Hu

  • 1Department of Cardiothoracic Surgery, Second Xiangya Hospital, Central South University, Changsha 410011, China. zhuangwei1005@163.com

Insights

For Chinese patients receiving mechanical heart valves, a lower anticoagulation intensity (INR 1.4-2.0) effectively reduces bleeding complications while preventing clots. Close monitoring in the first month post-operation is crucial for stable INR levels.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Pharmacology

Context:

  • Mechanical heart valve prostheses require lifelong anticoagulation therapy.
  • Optimal anticoagulation intensity is crucial to balance bleeding and thromboembolic risks.
  • Previous studies have not definitively established optimal anticoagulation targets for Chinese populations.

Purpose:

  • To determine the optimal intensity of anticoagulation for Chinese patients with mechanical heart valve prostheses.
  • To compare complication rates (hemorrhage and thromboembolism) at a target INR of 1.4-2.0.
  • To analyze INR variations during follow-up periods.

Summary:

  • A study of 178 patients with Carbomedics mechanical valves found hemorrhage (5.83%) to be more common than thromboembolism (0.26%) at a target INR of 1.4-2.0.
  • The final mean INR was 1.68 ± 0.38, with the highest INR instability observed in the first month post-operation.
  • Low-dose anticoagulation (INR 1.4-2.0) effectively reduced hemorrhagic events and prevented thromboembolic events.

Impact:

  • This research provides evidence-based recommendations for anticoagulation management in Chinese patients with mechanical heart valves.
  • Highlights the importance of intensive INR monitoring during the critical first month after valve replacement.
  • Aims to improve patient outcomes by minimizing anticoagulant-related complications.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...